Success Metrics

Clinical Success Rate
89.7%

Based on 165 completed trials

Completion Rate
90%(165/184)
Active Trials
8(4%)
Results Posted
45%(75 trials)
Terminated
19(9%)

Phase Distribution

Ph phase_1
28
13%
Ph phase_2
52
24%
Ph early_phase_1
4
2%
Ph not_applicable
48
22%
Ph phase_3
37
17%
Ph phase_4
46
21%

Phase Distribution

32

Early Stage

52

Mid Stage

83

Late Stage

Phase Distribution215 total trials
Early Phase 1First-in-human
4(1.9%)
Phase 1Safety & dosage
28(13.0%)
Phase 2Efficacy & side effects
52(24.2%)
Phase 3Large-scale testing
37(17.2%)
Phase 4Post-market surveillance
46(21.4%)
N/ANon-phased studies
48(22.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.4%

165 of 191 finished

Non-Completion Rate

13.6%

26 ended early

Currently Active

8

trials recruiting

Total Trials

221

all time

Status Distribution
Active(11)
Completed(165)
Terminated(26)
Other(19)

Detailed Status

Completed165
Terminated19
unknown19
Recruiting7
Withdrawn7
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
221
Active
8
Success Rate
89.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (1.9%)
Phase 128 (13.0%)
Phase 252 (24.2%)
Phase 337 (17.2%)
Phase 446 (21.4%)
N/A48 (22.3%)

Trials by Status

recruiting73%
not_yet_recruiting21%
completed16575%
enrolling_by_invitation10%
withdrawn73%
terminated199%
unknown199%
active_not_recruiting10%

Recent Activity

Clinical Trials (221)

Showing 20 of 221 trialsScroll for more
NCT07681076Phase 4

Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers

Recruiting
NCT03817970Phase 3

Cisplatin Disposition and Kidney Injury

Active Not Recruiting
NCT07334223Not Applicable

Comparison of Intravenous Ondansetron and Low Dose Ketamine in Preventing Post Spinal Shivering

Completed
NCT07793760Phase 4

Dexamethasone Versus Ondansetron for Preventing Post-Spinal Hypotension in Preeclampsia

Not Yet Recruiting
NCT07795060Phase 2

Ondansetron to Prevent Oral Rehydration Failure in Children With Cholera

Not Yet Recruiting
NCT04209595Phase 1

PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers

Completed
NCT07381634Phase 2

The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities

Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT05872893Phase 3

Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone

Completed
NCT05378113Phase 2

Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial

Terminated
NCT03593811Early Phase 1

Noninvasive Markers of Functional Nausea in Children

Completed
NCT06861010Phase 3

Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Recruiting
NCT05692245Phase 4

Dexamethasone vs Ondansetron After Cesarean Delivery

Completed
NCT02858310Phase 1

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Completed
NCT02106494Phase 3

A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC

Completed
NCT07310563Phase 1

A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity

Completed
NCT05035407Phase 1

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

Terminated
NCT04150614Phase 4

BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

Recruiting
NCT05439772Phase 4

Examining the Effect of Ondansetron on Bowel Prep Success

Completed
NCT04169828Not Applicable

The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis

Completed

Drug Details

Intervention Type
DRUG
Total Trials
221